XML 128 R104.htm IDEA: XBRL DOCUMENT v3.10.0.1
Other (Income) Expense, Net - Narrative (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2016
Component of Other Income / Expense of Nonoperating [Line Items]      
Litigation settlement, gain (loss) $ 0 $ 0 $ (625)
Goodwill impairment charges 144 38  
Write-down of assets held for sale 41    
Loss on extinguishment of debt   191  
Interest paid 777 723 686
Healthcare Services      
Component of Other Income / Expense of Nonoperating [Line Items]      
Goodwill impairment charges 144    
CGRP receptor antagonists      
Component of Other Income / Expense of Nonoperating [Line Items]      
Gain (loss) on sale of clinical development programs 85   100
AstraZeneca LP      
Component of Other Income / Expense of Nonoperating [Line Items]      
Other income 99 $ 232 98
Patent litigation      
Component of Other Income / Expense of Nonoperating [Line Items]      
Litigation settlement, gain (loss) $ 115   $ 117